z-logo
open-access-imgOpen Access
MP04-02 5-ALPHA REDUCTASE INHIBITORS AND THE RISK OF PROSTATE CANCER MORTALITY IN MEN TREATED FOR BENIGN PROSTATIC HYPERPLASIA
Author(s) -
Lauren P. Wallner,
Julia DiBello,
Bonnie Li,
Stephen Van Den Eeden,
Sheila Weinmann,
Debra P. Ritzwoller,
Jill E. Abell,
Ralph B. D’Agostino,
Ronald K. Loo,
David S. Aaronson,
Kathryn Richert-Boe,
Ralph I. Horwitz,
Steven J. Jacobsen
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.1937
Subject(s) - medicine , prostate cancer , cancer , 5 alpha reductase inhibitor , hyperplasia , prostate , gerontology , psychoanalysis , finasteride , psychology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom